Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-18-001466

Chief Operating Officer sold 20,000 shares at $3.69 ($73,800)

  • Chief Operating Officer acquired 175,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

GIVEN BRUCE D · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-01-01 Grant or award : show line 1 in the form +175,000 948,356 D
2018-01-01 Sale : show line 2 in the form −20,000 $3.69 $73,800 928,356 D
Open-market sales · 20,000 sh · avg $3.69 · $73,800
Loading xslF345X03/doc4.xml…